e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Assessment of lung function and side-effects in various diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alveolar hemorrhage due to imidazole treatment
M. Uyar, O. Elbek, O. Dikensoy, S. Ekiz, N. Bayram, M. Tülü, K. Bakir, A. Filiz, E. Ekinci (Gaziantep, Turkey)
Source:
Annual Congress 2005 - Assessment of lung function and side-effects in various diseases
Session:
Assessment of lung function and side-effects in various diseases
Session type:
Thematic Poster Session
Number:
3416
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Uyar, O. Elbek, O. Dikensoy, S. Ekiz, N. Bayram, M. Tülü, K. Bakir, A. Filiz, E. Ekinci (Gaziantep, Turkey). Alveolar hemorrhage due to imidazole treatment. Eur Respir J 2005; 26: Suppl. 49, 3416
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diffuse alveolar haemorrhage
Source: Eur Respir Monogr 2019; 86: 173-187
Year: 2019
Occult alveolar haemorrhage in pulmonary veno-occlusive disease
Source: Eur Respir J 2006; 27: 108-113
Year: 2006
Resolution of alveolar edema
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child
Source: Eur Respir J 2003; 22: Suppl. 45, 309s
Year: 2003
Alveolar hemorrhage syndrome in children
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage
Source: International Congress 2017 – Paediatric bronchology
Year: 2017
Lobar atelectasis in cystic fibrosis and treatment with bronchoscopically administered DNase
Source: Eur Respir J 2003; 22: Suppl. 45, 429s
Year: 2003
Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
From alveolar haemorrhage to pulmonary renal syndrome
Source: Annual Congress 2011 - Vasculitis and the lung
Year: 2011
Alveolar proteinosis: bronchopulmonary lavage - procedure and complications
Source: Eur Respir J 2002; 20: Suppl. 38, 616s
Year: 2002
Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Intrapleural streptokinase treatment of complicated parapneumonic effusions and empyemas
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005
Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004
Bilateral pleural effusions associated with pravastatin sodium treatment
Source: Eur Respir J 2007; 30: 1022
Year: 2007
Effectiveness of corticosteroid in diffuse alveolar hemorrhage with hematologic malignancy
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Effect of Disodium Etidronate in Patient With Pulmonary Alveolar Microlithiasis
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Treatment of pulmonary alveolar proteinosis (PAP) with administration of GM-CSF
Source: Eur Respir J 2002; 20: Suppl. 38, 447s
Year: 2002
Talc slurry vs bleomycin in treatment of malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept